India, Aug. 3 -- On Monday, Cybin D/B/A Helus Pharma (HELP) announced that it has appointed Michael Halstead as Chief Executive Officer, effective immediately.
Halstead brings 25 years of industry experience, most recently serving as President of Intra-Cellular Therapies, Inc. (ITCI).
Before Intra-Cellular, Halstead was a senior leader at Warner Chilcott plc.
In the pre-market activity on the Nasdaq, the shares were trading 0.90 percent lower at $7.75, after closing Friday's closing 3.93 percent down
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....